Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
Saved in:
| Published in: | Breast Cancer : Targets and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
- Genetic Correlation of miR-423 Polymorphism rs8067576 with Progression and Prognosis of Triple-Negative Breast Cancer
- LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p
- Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations
- Stem cell–mediated neuroplasticity and psychological recovery in cancer survivors: Mechanisms, evidence, and translational challenges
- Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer
- Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence